Consensus Alkem Laboratories Limited

Stocks

ALKEM

INE540L01014

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:07 07/08/2026 pm IST			5-day change	1st Jan Change
5,620.00 ^INR	+0.40%		-2.29%	+2.06%

03/08	Alkem Laboratories Limited Announces Appointment of Rajpal Singh Rana to Senior Management Position, Effective August 03, 2026	CI
23/07	Alkem Laboratories Limited Announces Resignation of Resignation of Jitendra Singh Huda as Senior Management Personnel, Effective from July 23, 2026	CI

Evolution of the Average Target: Alkem Laboratories Limited

Evolution of the Target Price: Alkem Laboratories Limited

Changes in Analyst Recommendations: Alkem Laboratories Limited

64a0183a03c4c62739c2547751b.eka8Odn_IN_nDNLHwhQUMLeHBXSY7URCZQc3uytZ4PM.SnfPXZ6pReadTZ__q2AsXePxPSHNl3wJNUlP-R4dlpA2JdJvlaBOrdJEoQ~6a9cdf0ab3bba4bbdb1e0a76489d49f6

Analysts' recommendations: Alkem Laboratories Limited

29/05	Bob Capital Markets Downgrades Alkem Laboratories to Sell From Hold; Price Target is INR4,638	MT
29/05	Jefferies Adjusts Alkem Laboratories' Price Target to INR6,500 From INR6,550, Keeps at Buy	MT
16/02	Nomura Adjusts Alkem Laboratories' Price Target to INR6,890 From INR 6,860, Keeps at Buy	MT
16/02	IIFL Upgrades Alkem Laboratories to Buy from Add, Price Target is INR6,300	MT
17/11	Nomura Adjusts Alkem Laboratories' Price Target to INR6,860 From INR6,300, Keeps at Buy	MT
22/25/22	Nomura Adjusts Alkem Laboratories' Price Target to INR6,300 From INR5,430, Keeps at Buy	MT
13/25/13	Jefferies Upgrades Alkem Laboratories to Buy From Underperform, Adjusts Price Target to INR6,000 From INR4,460	MT
30/25/30	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,460 From INR4,580, Keeps at Underperform	MT
27/25/27	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR5,430 From INR5,670	MT
10/25/10	Nomura Adjusts Alkem Laboratories' Price Target to INR5,670 From INR6,097, Keeps at Neutral	MT
10/25/10	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,580 From INR5,080, Keeps at Underperform	MT
15/24/15	Nomura Adjusts Alkem Laboratories' Price Target to INR6,097 From INR6,061, Keeps at Neutral	MT
14/24/14	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,950 From INR5,080, Keeps at Underperform	MT
14/24/14	Nomura Adjusts Alkem Laboratories' Price Target to INR6,061 From INR5,605, Keeps at Neutral	MT
12/24/12	Jefferies Adjusts Alkem Laboratories' Price Target to INR5,080 From INR4,200, Keeps at Underperform	MT
30/24/30	Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,200 From INR4,470, Keeps at Underperform	MT
12/24/12	Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,470 From INR3,960, Keeps at Underperform	MT
09/23/09	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR4,963 From INR3,632	MT
08/23/08	Jefferies Adjusts Alkem Laboratories’ Price Target to INR3,600 From INR3,550, Keeps at Underperform	MT
11/23/11	Jefferies Adjusts Alkem Laboratories' Price Target to INR3,550 From INR2,800, Keeps at Underperform	MT
23/23/23	Nomura Downgrades Alkem Laboratories to Neutral From Buy, Adjusts Price Target to INR3,632 From INR3,772	MT
14/23/14	Nomura Adjusts Alkem Laboratories' Price Target to INR3,772 From INR3,602, Keeps at Buy	MT
13/23/13	Jefferies Adjusts Alkem Laboratories' Price Target to INR2,800 From INR2,600, Keeps at Underperform	MT
10/23/10	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR3,602 From INR3,487	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALKEM LABORATORIES LIMITED					+6.14%
	ELI LILLY AND COMPANY					+9.01%
	JOHNSON & JOHNSON					+5.12%
	ABBVIE INC.					+11.51%
	ROCHE HOLDING AG					+0.82%
	NOVARTIS AG					-1.22%
	ASTRAZENECA PLC					+31.69%
	AMGEN INC.					-7.94%
	NOVO NORDISK A/S					+3%
	GILEAD SCIENCES, INC.					+18.16%
	Average					+7.63%
	Weighted average by Cap.					+7.57%